Makale
Tam Makale
Uluslararası
2020
Possible contribution of the neprilysin/ACE pathway to sepsis in mice
Life sciences
Cilt 258 · 01.10.2020
Özet
Aim: Omapatrilat is an antagonist of angiotensin-converting (ACE) and neprilysin-neuropeptidase (NEP) enzymes. The aim of our study is to show that omapatrilat may have beneficial effects as a treatment for polymicrobial sepsis.
Anahtar kelimeler
cytokines
mice
SEPSIS
PERMEABILITY
Rat model
INFARCTION
angiotensin converting enzyme
neprilysin
omapatrilat
ATRIAL-NATRIURETIC-PEPTIDE
ACE
ACUTE LUNG INJURY
VASOPEPTIDASE INHIBITOR OMAPATRILAT
ACUTE RESPIRATORY-DISTRESS
CANDESARTAN
Sürdürülebilir Kalkınma Amaçları
-
SKA 3: Sağlıklı Bireyler
Atıf için künye
Uğan, R. A., Un, H., Gürbüz, M. A., Kaya, G., Kahramanlar, A., Aksakalli-Magden, Z. B., Halıcı, Z., & Çadırcı, E. (2020). Possible contribution of the neprilysin/ACE pathway to sepsis in mice. Life sciences, 258. https://doi.org/10.1016/j.lfs.2020.118177
BibTeX
@article{ugan2020-24461,
author = {Uğan, Rüstem Anıl and Un, Harun and Gürbüz, Muhammet Ali and Kaya, Gokce and Kahramanlar, Aysenur and Aksakalli-Magden, Zeynep Berna and Halıcı, Zekai and Çadırcı, Elif},
title = {Possible contribution of the neprilysin/ACE pathway to sepsis in mice},
journal = {Life sciences},
year = {2020},
volume = {258},
issn = {0024-3205},
doi = {10.1016/j.lfs.2020.118177},
url = {https://akademik.atauni.edu.tr/yayinlar/24461-possible-contribution-of-the-neprilysinace-pathway-to-sepsis-in-mice}
}